Company structures leadership to support strategic plans
COPPELL, Texas--(BUSINESS WIRE)--May 19, 2014--
Mannatech®,
Incorporated (NASDAQ: MTEX), the pioneer of nutritional
glycobiology, and leading innovator of naturally-sourced
supplements based on Real
Food Technology® solutions, and creator
of the M5MSM (Mission
5 MillionSM) social entrepreneurial
movement, announced updates and additions to its executive management
team and corporate structure to further support its strategic plans.
Joel Bikman is joining the company as Chief Marketing Officer. Bob Adam
has been named General Manager, U.S. Sales, and Terrie Bayless has been
named Assistant General Manager, U.S. Sales.
Joel Bikman joins Mannatech as Chief Marketing Officer, with many years
of experience in marketing within both the direct sales and nutritional
supplements industry. As Chief Marketing Officer for Mannatech, Mr.
Bikman will oversee the company’s efforts in product marketing, creative
services, communication and overall strategic marketing and research.
Mr. Bikman most recently served as Senior Vice President of Sales and
Marketing for TriVita, a wellness and services company based in
Scottsdale, Arizona. Previously, Mr. Bikman served as Vice President of
Marketing at Freelife International in Phoenix, Arizona, and also Vice
President of Marketing at Isagenix International in Chandler, Arizona.
Prior to his entry into direct sales, Joel Bikman served as Account
Supervisor at Cramer-Krasselt, the second-largest independent
advertising agency in the country. Mr. Bikman holds a BA in
Communications and an MBA from Brigham Young University in Provo, Utah.
Bob Adam will now serve Mannatech as General Manager, U.S. Sales. In
this new role, he will oversee all sales and Associate advocacy efforts
specifically for the U.S. market. Bob joined the corporate team in 2004,
and served as an Independent Associate leader from 1997 until that time.
Mr. Adam has consistently made a significant, measurable impact on
Mannatech’s field relations since joining the corporate team. Most
recently, he created and led the Flight Team program, which focuses on
training and coaching of both new and veteran leaders within the company.
Terrie Bayless will now serve as Assistant General Manager, U.S. Sales.
Terrie is celebrating her 20th year with Mannatech. During
that time, Terrie has served several roles within the Sales and
Marketing organization. Her extensive experience and awareness of
company culture and sales operations will provide much value in serving
as an advocate for Associate needs.
“As Mannatech continues to evolve and increasingly dedicate itself to
our Mission 5 Million movement, it’s important to align the corporate
organization and support our Independent Associates in a way that moves
our vision forward as effectively and efficiently as possible,” said Dr.
Robert A. Sinnott, CEO and Chief Science Officer. “I’m honored to add
Joel Bikman to our team. His expertise in both marketing and direct
sales provides a true advantage for Mannatech for the future. I’m also
pleased to have Bob Adam and Terrie Bayless step into new roles, where
they can exercise not only their professional knowledge and leadership,
but also their heart for and experience with Mannatech and its
Associates in more influential ways.”
Individuals interested in Mannatech’s products or exploring its business
opportunity are encouraged to learn more at Mannatech.com.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales Associates around the globe including the United
States, United Kingdom, Canada, South Africa, Australia, New Zealand,
Austria, Denmark, Germany, Norway, Sweden, the Netherlands, Japan,
Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech
Republic, the Republic of Korea, Mexico and Hong Kong. For more
information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain Associates and
Members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
Source: Mannatech, Incorporated
Mannatech, Incorporated
Ben Hulet, 972-471-7224
bhulet@mannatech.com